Search
for
Sort by
Research 31–60 of 1000+
- Pattern of Skin disorders across age groups
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Obesity and the skin
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- National scientific medical meeting 1996 abstracts
- Kawasaki disease: an update
- Approach to Patients with Suspected Rheumatic Disease
- Rheumatologic Manifestations of Pregnancy
- Geriatric Dermatologic Therapy
- The Clinical Presentation of Systemic Lupus Erythematosus
- Guía de Procedimientos en Cirugía Plástica Reconstructiva Vol. 4
- REVIEW OF SO-CALLED ASEPTIC NEUTROPHILIC DERMATOSES
- ‘Disappearing Foot Disease’: An Unusual Presentation of Primary Lymphoma of Bone
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review
- Validity and Advantages of Three-Dimensional High-Frequency Ultrasound in Dermatological Evaluation
- Primary Follicular Dystrophy With Scarring Dermatitis in C57BL/6 Mouse Substrains Resembles Central Centrifugal Cicatricial Alopecia in Humans
- JAK inhibitors in dermatology: The promise of a new drug class
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Vaccines, adjuvants and autoimmunity
- The use of cyclosporine in dermatology: Part I
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- ESCITALOPRAM
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Sustaining treatment response in alopecia areata through tofacitinib dose tapering: A single-center retrospective study
- TONGUE, RED
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Clinical manifestations of cutaneous lupus erythematosus